ABVX.PA ABIVAX Société Anonyme
Company Analysis
Latest News
🔴 ABIVAX is trading 4.4% down today amid broader market and biotech-sector weakness
ABIVAX is trading 4.4% down at €78.10, amid broader market and biotech-sector weakness rather than a clear new company-specific catalyst. - Global stocks were...
🟢 ABIVAX is trading 6.8% up today amid a biotech-sector rally
ABIVAX is trading at €83.25, up 6.80%, amid a biotech-sector rally. - The XBI was up 2.10% during the regular session, with sector sentiment supported by M&A...
🟢 ABIVAX is trading 4.04% up today amid a biotech-sector rally
ABIVAX is trading at €81.10, up 4.04%, amid a biotech-sector rally; no confirmed ABIVAX-specific announcement explaining the October 20 move surfaced. - The...
🔴 ABIVAX is trading 4.05% down
ABIVAX is trading 4.05% lower at €75.75; no confirmed new October 19 catalyst is provided. - The latest reported close was €78.95 on October 16, down 3.66%. -...
🟢 ABIVAX is trading 4.22% up today — no clear catalyst identified
ABIVAX is trading 4.22% up at €80.20; available evidence does not establish a catalyst for the October 14 move. - No clear company-specific announcement...
🟢 ABIVAX is trading 4.2% up amid stronger biotech-sector sentiment
ABIVAX is trading 4.22% higher at €80.35 on October 9, 2026, amid stronger biotech-sector sentiment, with no clear company-specific announcement explaining the...
🔴 ABIVAX is trading 4% down today amid French fiscal and political uncertainty
ABIVAX is trading at €80.15, with a -4.01% change; broader French-market weakness is the clearest available context for the decline. - No verified...
🔴 ABIVAX is trading 4.16% down
ABIVAX is trading at €84.15, down 4.16%, with no confirmed company-specific catalyst reported for the October 1 decline. - The CAC 40 fell 1.62% and the SBF...
🔴 ABIVAX is trading 4.3% down with no confirmed catalyst
ABIVAX is trading 4.33% down at €84.00, with no specific company news confirmed as the cause. - On September 30, ABIVAX announced seven obefazimod abstracts...
🟢 ABIVAX is trading 4.7% up
ABIVAX is trading 4.71% up at €87.80, with no specific catalyst confirmed for the September 30, 2026 move. - On September 30, the company announced it will...
🟢 ABIVAX is trading 4.11% up — catalyst remains unclear
ABIVAX is trading at €87.30, up 4.11%, with the move’s specific catalyst unclear. - No clear company-specific announcement explaining the September 30, 2026...
ABIVAX Falls 4% as Wall Street Zen Cuts Rating to Sell
ABIVAX Société Anonyme (ABVX.PA) was downgraded by Wall Street Zen from Hold to Sell on Saturday. The clinical-stage biotech reported a quarterly loss of...
ABIVAX Named Guggenheim Top Biotech Pick, Citing 2029 Cash Runway
Guggenheim Securities named ABIVAX its top biotechnology pick following first-half 2026 earnings. The firm reiterated a Buy rating for the stock. Guggenheim...
🔴 ABIVAX is trading 4.69% down today after first-half net loss widened to €165.9 million
ABIVAX is trading at €86.40, down 4.69% now, after first-half results showed a €165.9 million net loss, versus €100.8 million a year earlier. - September 21,...
🔴 ABIVAX is trading 5.82% down today after disappointing Ionis Pharmaceuticals trial results
ABIVAX is trading 5.82% down now at €93.85 after disappointing Ionis Pharmaceuticals trial results weakened sentiment across biotechnology. - The decline is...
🔴 ABIVAX is trading 4.16% down today after disappointing Ionis trial results
ABIVAX is trading at €95.50, down 4.16%, as broader biotech weakness intensified on September 15, 2026, following disappointing Ionis Pharmaceuticals trial...